ReviewGerontology2019
New Trend in Old-Age Mortality: Gompertzialization of Mortality Trajectory.
Review in Gerontology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 49 citations in OpenAlex.
- Global evidence for bounded human lifespan growth.Biogerontology · 2026Article
- Biological evidence of the life expectancy limit in human aging.GeroScience · 2026Article
- Gerontology lost in translation from demography to biology of aging and back.Biogerontology · 2026Review
- Time-constant absolute effect measures for time-to-event outcomes.BMC medical research methodology · 2025Article
- Review
- Associations Between Inflammatory Potential of Diet with the Risk of All-Cause Mortality and Greenhouse Gas Emissions in Chinese Adults.Nutrients · 2025Article
- The Compensation Effect of Mortality: A Global Analysis of Human Populations.Ageing and longevity research · 2025Article
- Circadian rhythm analysis using wearable-based accelerometry as a digital biomarker of aging and healthspan.NPJ digital medicine · 2024Article
- Exploring Patterns of Human Mortality and Aging: A Reliability Theory Viewpoint.Biochemistry. Biokhimiia · 2024Review
- Ageing as a two-phase process: theoretical framework.Frontiers in aging · 2024Article
- Biological Restraints on Indefinite Survival.Cold Spring Harbor perspectives in medicine · 2023Review
- Why Gilgamesh failed: the mechanistic basis of the limits to human lifespan.Nature aging · 2022Review
- Centenarians may hold a key to continued rise of human longevity.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Information measures and design issues in the study of mortality deceleration: findings for the gamma-Gompertz model.Lifetime data analysis · 2021Article
- A natural constant predicts survival to maximum age.Communications biology · 2021Article
- Regularities in human mortality after age 105.PloS one · 2021Article
- Are We Approaching a Biological Limit to Human Longevity?The journals of gerontology. Series A, Biological sciences and medical sciences · 2020Article
- Exponential increase in mortality with age is a generic property of a simple model system of damage accumulation and death.PloS one · 2020Article
- THE EXPOSOME IN HUMAN EVOLUTION: FROM DUST TO DIESEL.The Quarterly review of biology · 2019Article
- DNA damage responses in ageing.Open biology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
There is great interest among gerontologists, demographers, and actuaries in the question concerning the limits to human longevity. Attempts at getting answers to this important question have stimulated many studies on late-life mortality trajectories, often with opposing conclusions. One group of researchers believes that mortality stops growing with age at extreme old ages, and that hence there is no fixed limit to the human life span. Other studies found that mortality continues to grow with age up to extreme old ages. Our study suggests a possible solution to this controversy. We found that mortality deceleration is best observed when older, less accurate life span data are analyzed, while in the case of more recent and reliable data there is a persistent mortality growth with age. We compared the performance (goodness of fit) of two competing mortality models - the Gompertz model and the Kannisto ("mortality deceleration") model - at ages of 80-105 years using data for 1880-1899 single-year birth cohorts of US men and women. The mortality modeling approach suggests a transition from mortality deceleration to the Gompertzian mortality pattern over time for both men and women. These results are consistent with the hypothesis about disappearing mortality deceleration over time due to improvement in the accuracy of age reporting. In the case of more recent data, mortality continues to grow with age even at very old ages. This observation may lead to more conservative estimates of future human longevity records.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.